Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 1995; 74(01): 511-514
DOI: 10.1055/s-0038-1642730
DOI: 10.1055/s-0038-1642730
Symposium
Clinical Coagulation Laboratory and Oral Anticoagulant Therapy Treatment
Clinical Coagulation Laboratory and Oral Anticoagulant Therapy Treatment. Instrumentation and Methodology
Authors
Further Information
Publication History
Publication Date:
09 July 2018 (online)
-
References
- 1 Hirsh J. Oral anticoagulant drugs. N Engl J Med 1991; 324: 1865-75
- 2 Ansell JE. Oral anticoagulant therapy-50 years later. Arch Intern Med 1993; 153: 586-596
- 3 British Society for Haematology. Guidelines on oral anticoagulation: second edition. J Clin Pathol. 1990; 43: 177-183
- 4 Fihn SD, McDonell M, Martin D, Henikoff J, Vermes D, Kent D, White RH. Risk factor for complications of chronic anticoagulation. A multicenter study. Ann Intern Med 1993; 118: 511-20
- 5 WHO Expert Committee on Biological Standardization. 31st Report. WHO Tech Ser 1981; 658: 185-205
- 6 Poller L, Tabemer DA, Thomson JM, Darby KV. Survey of prothrombin time results in National External Quality Assessment Scheme exercises 1980-87. J Clin Pathol 1988; 41: 361-4
- 7 Brophy MT, Fiore LD, Lau J, Goodwin R, Lopez A, Deykin D. Comparison ofa standard and a sensitive thromboplastin in monitoring low intensity oral anticoagulant therapy. Am J Clin Pathol 1994; 102: 134-137
- 8 Bader R, Mannucci PM, Tripodi A, Hirsh J, Keller F, Solleder EM, Hawkins P, Peng M, Pelzer H, Teijdor LM, Ramirez IF, Kolde HJ. Multicentric evaluation of a new PT reagent based on recombinant human tissue factor and synthetic phospholipids. Thromb Haemostas 1994; 71: 292-299
- 9 Finazzi G, Falanga A, Galli M, Cortelazzo S, Remuzzi A, Barbui T. Recombinant versus high-sensitivity conventional thromboplastin: a randomized clinical study in patients on oral anticoagulation. Thromb Haemostas 1994; 72: 804-807
- 10 Eckman MH, Levine HI, Pauker SG. Effect of laboratory variation in the prothrombin-time ratio on the results of oral anticoagulant therapy. N Engl J Med 1993; 329: 696-702
- 11 Kitchen S, Walker ID, Woods TAL. Preston. Thromboplastin related differences in the determination of International Normalised Ratio: a cause for concern . Thromb Haemostas 1994; 72: 426-429
- 12 Becker DM, Humphries JE, Walker FB, DeMong LK, Bopp JS, Acker MN. Standardizing the prothrombin time:calibrating coagulation instruments as well as thromboplastin. Arch Pathol Lab Med 1993; 117: 602-605
- 13 Cunningham M, Johnson GF, Pennell BJ, Olson JD. The reliability of manufactuter-determined, instrument-specific international sensitivity index for calculating the international normalized ratio. Am J Qin Pathol 1994; 102: 128-133
- 14 Van Dijk-Wierda CA, Loeliger EA, Meilof J, Roos J. Anticoagulant control in the Netherlands. Lancet 1981; 1: 1321-1322
- 15 Kumar S, Haigh JRM, Rhodes LE, Peaker S, Davies JA, Roberts BE, Feely MP. Poor compliance is a major factor in unstable outpatients control of anticoagulant therapy. Thromb Haemostas 1989; 62: 729-732
- 16 Van den Besselaar AMHP, Van der Meer FJM, Gerrits-Drabbe CW. Therapeutic control of oral anticoagulant treatment in the Netherlands. Am J Clin Pathol 1988; 90: 685-690
- 17 Azar AJ, Deckers JW, Rosendaal FR, Van Bergen PFMM, Van der Meer FJM, Janker JJC, Briet E. Assessment of therapeutic quality control in a long-term anticoagulant trial in post-myocardial infarction patients. Thromb Haemostas 1994; 72: 347-351
- 18 Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications inpatients with mechanical heart valve prostheses. Circulation 1994; 89: 635-641
- 19 Cortelazzo S, Finazzi G, Viero P, Galli M, Remuzzi A, Parenzan L, Barbui T. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Thromb Haemostas 1993; 69: 316-320
- 20 Taylor F, Ramsay M, Covell B, Gaminara L, Them son D, Cohen H, Voke J. Management of expanding anticoagulant clinics: a role for general practitioners. Br J Haematol 1994; 86 (01) 68 Abstract
- 21 Anderson DR, Harrison L, Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Arch Inter Med 1993; 153: 1441-1447
- 22 Patel N, Ostrovsky D, Fish L, Nozzolillo E, Peterson A, Ansell J. Long-term patient self-monitoring and self-management of oral anticoagulation therapy with a capillary whole blood analyzer. Blood 1994; 84 (01) 69a Abstract
- 23 Tripodi A, Arbini A, Chantarangkul V, Bettega D, Mannucci PM. Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the International Normalized Ratio. Thromb Haemostas 1993; 70: 921-924